相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Standardized monitoring of cytomegalovirus-specific immunity can improve risk stratification of recurrent cytomegalovirus reactivation after hematopoietic stem cell transplantation
Eva Wagner-Drouet et al.
HAEMATOLOGICA (2021)
CMV viral load kinetics as surrogate endpoints after allogenic transplantation
Elizabeth R. Duke et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Letermovir as Salvage Therapy for Cytomegalovirus Infection in Transplant Recipients
Pakpoom Phoompoung et al.
TRANSPLANTATION (2020)
A Mortality Analysis of Letermovir Prophylaxis for Cytomegalovirus (CMV) in CMV-seropositive Recipients of Allogeneic Hematopoietic Cell Transplantation
Per Ljungman et al.
CLINICAL INFECTIOUS DISEASES (2020)
Effects of Maribavir on P-Glycoprotein and CYP2D6 in Healthy Volunteers
Ivy H. Song et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2020)
Differences in Duration and Degree of Cytomegalovirus DNAemia Observed With Two Standardized Quantitative Nucleic Acid Tests and Implications for Clinical Care
Atibordee Meesing et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
The pipeline of antiviral T-cell therapy: what's in the clinic and undergoing development
Alyssa Fatic et al.
TRANSFUSION (2020)
Letermovir for Difficult to Treat Cytomegalovirus Infection in Lung Transplant Recipients
Tobias Veit et al.
TRANSPLANTATION (2020)
Impact of Fragmentation on Commutability of Epstein-Barr Virus and Cytomegalovirus Quantitative Standards
R. T. Hayden et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2020)
CMV infection management in transplant patients in Italy
Paolo Antonio Grossi et al.
JOURNAL OF CLINICAL VIROLOGY (2020)
Cytomegalovirus Humoral Response Against Epithelial Cell Entry-Mediated Infection in the Primary Infection Setting After Hematopoietic Cell Transplantation
Danniel Zamora et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Letermovir Resistance Analysis in a Clinical Trial of Cytomegalovirus Prophylaxis for Hematopoietic Stem Cell Transplant Recipients
Cameron M. Douglas et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Management of Ganciclovir Resistant Cytomegalovirus Retinitis in a Solid Organ Transplant Recipient: A Review of Current Evidence and Treatment Approaches
L. Fu et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2020)
Monitoring of CMV-specific cell-mediated immunity with a commercial ELISA-based interferon-γ release assay in kidney transplant recipients treated with antithymocyte globulin
Mario Fernandez-Ruiz et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2020)
Outcomes of patients with detectable CMV DNA at randomization in the phase III trial of letermovir for the prevention of CMV infection in allogeneic hematopoietic cell transplantation
Francisco M. Marty et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2020)
Poxvirus Vectored Cytomegalovirus Vaccine to Prevent Cytomegalovirus Viremia in Transplant Recipients A Phase 2, Randomized Clinical Trial
Ibrahim Aldoss et al.
ANNALS OF INTERNAL MEDICINE (2020)
Phase 2 Study of Anti-Human Cytomegalovirus Monoclonal Antibodies for Prophylaxis in Hematopoietic Cell Transplantation
Johan Maertens et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Advances in the genotypic diagnosis of cytomegalovirus antiviral drug resistance
Sunwen Chou
ANTIVIRAL RESEARCH (2020)
Characterization of the dynamics of human cytomegalovirus resistance to antiviral drugs by ultra-deep sequencing
Helene Guermouche et al.
ANTIVIRAL RESEARCH (2020)
Infections after Allogenic Transplant with Post-Transplant Cyclophosphamide: Impact of Donor HLA Matching
Chiara Oltolini et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Incidence, risk factors, and outcomes of cytomegalovirus retinitis after haploidentical hematopoietic stem cell transplantation
Chen-Hua Yan et al.
BONE MARROW TRANSPLANTATION (2020)
Burden and Timeline of Infectious Diseases in the First Year After Solid Organ Transplantation in the Swiss Transplant Cohort Study
Christian van Delden et al.
CLINICAL INFECTIOUS DISEASES (2020)
Cellular Immunity to Predict the Risk of Cytomegalovirus Infection in Kidney Transplantation: A Prospective, Interventional, Multicenter Clinical Trial
Marta Jarque et al.
CLINICAL INFECTIOUS DISEASES (2020)
Clinically significant drug interaction: letermovir and voriconazole
Arianne Duong et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
Earliest cases of coronavirus disease 2019 (COVID-19) identified in solid organ transplant recipients in the United States
Olivia S. Kates et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2020)
COVID-19 in solid organ transplant recipients: A single-center case series from Spain
Mario Fernandez-Ruiz et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2020)
Successful recovery of COVID-19 pneumonia in a renal transplant recipient with long-term immunosuppression
Lan Zhu et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2020)
COVID-19 in kidney transplant recipients
Ilaria Gandolfini et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2020)
Effect of Preemptive Therapy vs Antiviral Prophylaxis on Cytomegalovirus Disease in Seronegative Liver Transplant Recipients With Seropositive Donors A Randomized Clinical Trial
Nina Singh et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Covid-19 and Kidney Transplantation
Enver Akalin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Donor CMV-specific cytotoxic T lymphocytes successfully treated drug-resistant cytomegalovirus encephalitis after allogeneic hematopoietic stem cell transplantation
Peng Ke et al.
HEMATOLOGY (2020)
Autologous Adoptive T-cell Therapy for Recurrent or Drug-resistant Cytomegalovirus Complications in Solid Organ Transplant Recipients: A Single-arm Open-label Phase I Clinical Trial
Corey Smith et al.
CLINICAL INFECTIOUS DISEASES (2019)
PBPK Modeling Strategy for Predicting Complex Drug Interactions of Letermovir as a Perpetrator in Support of Product Labeling
Ying-Hong Wang et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Clinical development of letermovir and maribavir: Overview of human cytomegalovirus drug resistance
Jocelyne Piret et al.
ANTIVIRAL RESEARCH (2019)
Detection of CMV Antiviral Resistance Mutations to Letermovir in Patients Using a Validated Clinical Sequencing Assay
James Grantham et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation
Francisco M. Marty et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Strategies of adoptive T -cell transfer to treat refractory viral infections post allogeneic stem cell transplantation
Theresa Kaeuferle et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Pulmonary cytomegalovirus (CMV) DNA shedding in allogeneic hematopoietic stem cell transplant recipients: Implications for the diagnosis of CMV pneumonia
Jose Luis Pinana et al.
JOURNAL OF INFECTION (2019)
A Randomized Study of Quantiferon CMV-directed Versus Fixed-duration Valganciclovir Prophylaxis to Reduce Late CMV After Lung Transplantation
Glen P. Westall et al.
TRANSPLANTATION (2019)
Pharmacokinetic Drug-Drug Interactions Between Letermovir and the Immunosuppressants Cyclosporine, Tacrolimus, Sirolimus, and Mycophenolate Mofetil
Jacqueline B. McCrea et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Prospective Assessment of Cytomegalovirus Immunity in High-Risk Donor-Seropositive/Recipient-Seronegative Liver Transplant Recipients Receiving Either Preemptive Therapy or Antiviral Prophylaxis
Ajit P. Limaye et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL 7)
Per Ljungman et al.
LANCET INFECTIOUS DISEASES (2019)
Quantitative PCR Is Faster, More Objective, and More Reliable Than Immunohistochemistry for the Diagnosis of Cytomegalovirus Gastrointestinal Disease in Allogeneic Stem Cell Transplantation
Maria Suarez-Lledo et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Assessment and prevention of cytomegalovirus infection in allogeneic hematopoietic stem cell transplant and in solid organ transplant: A multidisciplinary consensus conference by the Italian GITMO, SITO, and AMCLI societies
Corrado Girmenia et al.
CLINICAL TRANSPLANTATION (2019)
Improvement in detecting cytomegalovirus drug resistance mutations in solid organ transplant recipients with suspected resistance using next generation sequencing
Ruben Lopez-Alad et al.
PLOS ONE (2019)
Pathogen-Specific T Cells Beyond CMV, EBV and Adenovirus
Wei Jiang et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2019)
Resistant or refractory cytomegalovirus infections after hematopoietic cell transplantation: diagnosis and management
Fareed Khawaja et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2019)
Maribavir for Preemptive Treatment of Cytomegalovirus Reactivation
Johan Maertens et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Use of Letermovir as Salvage Therapy for Drug-Resistant Cytomegalovirus Retinitis
Nicholas Turner et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Rapid Acquisition of Cytomegalovirus-Specific T Cells with a Differentiated Phenotype, in Nonviremic Hematopoietic Stem Transplant Recipients Vaccinated with CMVPepVax
Corinna La Rosa et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Maribavir for Refractory or Resistant Cytomegalovirus Infections in Hematopoietic-cell or Solid-organ Transplant Recipients: A Randomized, Dose-ranging, Double-blind, Phase 2 Study
Genovefa A. Papanicolaou et al.
CLINICAL INFECTIOUS DISEASES (2019)
The Ability of a Cytomegalovirus ELISPOT Assay to Predict Outcome of Low-Level CMV Reactivation in Hematopoietic Cell Transplant Recipients
Lynn El Haddad et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Strain-specific antibody therapy prevents cytomegalovirus reactivation after transplantation
Jose Paulo Martins et al.
SCIENCE (2019)
A prospective multicenter observational study of cell-mediated immunity as a predictor for cytomegalovirus infection in kidney transplant recipients
Deepali Kumar et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2019)
Improving our mechanistic understanding of the indirect effects of CMV infection in transplant recipients
Arnaud G. L'Huillier et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2019)
Cytomegalovirus colitis in inflammatory bowel disease and after haematopoietic stem cell transplantation: diagnostic accuracy, predictors, risk factors and disease outcome
Eirini Mavropoulou et al.
BMJ OPEN GASTROENTEROLOGY (2019)
A randomized, phase 2 study of ASP0113, a DNA-based vaccine, for the prevention of CMV in CMV-seronegative kidney transplant recipients receiving a kidney from a CMV-seropositive donor
Flavio Vincenti et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2018)
The Artemisinin Derivative Artemisone Is a Potent Inhibitor of Human Cytomegalovirus Replication
E. Oiknine-Djian et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Analysis of spontaneous resolution of cytomegalovirus replication after transplantation in CMV-seropositive patients with pretransplant CD8+IFNG + response
Aurora Paez-Vega et al.
ANTIVIRAL RESEARCH (2018)
Impact of Cytomegalovirus Viral Load on Probability of Spontaneous Clearance and Response to Preemptive Therapy in Allogeneic Stem Cell Transplantation Recipients
Jose F. Camargo et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Diagnostic utility of monitoring cytomegalovirus-specific immunity by QuantiFERON-cytomegalovirus assay in kidney transplant recipients
Dominika Deborska-Materkowska et al.
BMC INFECTIOUS DISEASES (2018)
Absolute Lymphocyte Count: A Predictor of Recurrent Cytomegalovirus Disease in Solid Organ Transplant Recipients
Bradley J. Gardiner et al.
CLINICAL INFECTIOUS DISEASES (2018)
Monitoring of Cytomegalovirus (CMV)-Specific Cell-Mediated Immunity in Heart Transplant Recipients: Clinical Utility of the QuantiFERON-CMV Assay for Management of Posttransplant CMV Infection
Angela Chiereghin et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2018)
Assessing the risk of CMV reactivation and reconstitution of antiviral immune response post bone marrow transplantation by the QuantiFERON-CMV-assay and real time PCR
Adalbert Krawczyk et al.
JOURNAL OF CLINICAL VIROLOGY (2018)
T-Track-CMV and QuantiFERON-CMV assays for prediction of protection from CMV reactivation in kidney transplant recipients
Smaranda Gliga et al.
JOURNAL OF CLINICAL VIROLOGY (2018)
Analysis of the QuantiFERON-CMV assay, CMV viraemia and antiviral treatment following solid organ transplantation in Western Australia
Grace Thompson et al.
PATHOLOGY (2018)
Quantiferon-Cytomegalovirus assay: A potentially useful tool in the evaluation of CMV-specific CD8+T-cell reconstitution in pediatric hematopoietic stem cell transplant patients
Bilio Paouri et al.
PEDIATRIC TRANSPLANTATION (2018)
Early viral-specific T-cell testing predicts late cytomegalovirus reactivation following liver transplantation
S. Sood et al.
TRANSPLANT INFECTIOUS DISEASE (2018)
Cytomegalovirus Viral Load in Bronchoalveolar Lavage to Diagnose Lung Transplant Associated CMV Pneumonia
Isabelle Paula Lodding et al.
TRANSPLANTATION (2018)
Valganciclovir Prophylaxis Versus Preemptive Therapy in Cytomegalovirus-Positive Renal Allograft Recipients: Long-term Results After 7 Years of a Randomized Clinical Trial
Oliver Witzke et al.
TRANSPLANTATION (2018)
The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation
Camille N. Kotton et al.
TRANSPLANTATION (2018)
Cytomegalovirus Disease After Liver Transplant-A Description of a Treatment-Resistant Case: A Case Report and Literature Review
P. Czarnecka et al.
TRANSPLANTATION PROCEEDINGS (2018)
Cytomegalovirus Infection Monitoring Based on Interferon Gamma Release Assay in Kidney Transplantation
M. d. C. De Gracia-Guindo et al.
TRANSPLANTATION PROCEEDINGS (2018)
Natural killer cells as a therapeutic tool for infectious diseases - current status and future perspectives
Stanislaw Schmidt et al.
Oncotarget (2018)
Real-time quantitative PCR analysis of endoscopic biopsies for diagnosing CMV gastrointestinal disease in non-HIV immunocompromised patients: a diagnostic accuracy study
Yasuhiro Tsuchido et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2018)
A fifty-year odyssey: prospects for a cytomegalovirus vaccine in transplant and congenital infection
Don Jeffrey Diamond et al.
EXPERT REVIEW OF VACCINES (2018)
Risk Factors for the Development of Cytomegalovirus Resistance in Solid Organ Transplantation: A Retrospective Case-Control Study
U. Sandkovsky et al.
TRANSPLANTATION PROCEEDINGS (2018)
Absolute Lymphocyte Count Thresholds: A Simple, Readily Available Tool to Predict the Risk of Cytomegalovirus Infection After Transplantation
Atibordee Meesing et al.
OPEN FORUM INFECTIOUS DISEASES (2018)
Less renal allograft fibrosis with valganciclovir prophylaxis for cytomegalovirus compared to high-dose valacyclovir: a parallel group, open-label, randomized controlled trial
Tomas Reischig et al.
BMC INFECTIOUS DISEASES (2018)
1531. A CMV Vaccine Based on Non-Replicating Lymphocytic Choriomeningitis Virus Vectors Expressing gB and pp65 Is Safe and Immunogenic in Healthy Volunteers, Allowing for Development of a Phase II Clinical Trial in Living Donor Kidney Transplant Recipients
Camille Nelson Kotton et al.
Open Forum Infectious Diseases (2018)
Antiviral prophylaxis for cytomegalovirus infection in allogeneic hematopoietic cell transplantation
Kaiwen Chen et al.
BLOOD ADVANCES (2018)
Use of Viral Load as a Surrogate Marker in Clinical Studies of Cytomegalovirus in Solid Organ Transplantation: A Systematic Review and Meta-analysis
Yoichiro Natori et al.
CLINICAL INFECTIOUS DISEASES (2018)
Cytomegalovirus (CMV) DNA quantification in bronchoalveolar lavage fluid of immunocompromised patients with CMV pneumonia
Elena Beam et al.
CLINICAL TRANSPLANTATION (2018)
Experience with leflunomide as treatment and as secondary prophylaxis for cytomegalovirus infection in lung transplant recipients: A case series and review of the literature
Jose Tiago Silva et al.
CLINICAL TRANSPLANTATION (2018)
Pharmacokinetics and Safety of Letermovir Coadministered With Cyclosporine A or Tacrolimus in Healthy Subjects
Dirk Kropeit et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2018)
Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of RG7667, a Combination Monoclonal Antibody, for Prevention of Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients
Julie H. Ishida et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials
Per Ljungman et al.
CLINICAL INFECTIOUS DISEASES (2017)
Progress in Quantitative Viral Load Testing: Variability and Impact of the WHO Quantitative International Standards
R. T. Hayden et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2017)
Stool cytomegalovirus polymerase chain reaction for the diagnosis of cytomegalovirus-related gastrointestinal disease
Noparat Prachasitthisak et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2017)
Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation
Ifigeneia Tzannou et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Inclusions or bystanders? CMV PCR sensitivity and specificity in tissue samples
John Burston et al.
JOURNAL OF CLINICAL VIROLOGY (2017)
Cytomegalovirus (CMV) DNA Quantitation in Bronchoalveolar Lavage Fluid From Hematopoietic Stem Cell Transplant Recipients With CMV Pneumonia
Michael Boeckh et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Cytomegalovirus-Specific T-Cell Transfer for Refractory Cytomegalovirus Infection After Haploidentical Stem Cell Transplantation: The Quantitative and Qualitative Immune Recovery for Cytomegalovirus
Xu-Ying Pei et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Characterization of Human Cytomegalovirus Genome Diversity in Immunocompromised Hosts by Whole-Genome Sequencing Directly From Clinical Specimens
Elias Hage et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Identifying Cytomegalovirus Complications Using the Quantiferon-CMV Assay After Allogeneic Hematopoietic Stem Cell Transplantation
Michelle K. Yong et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT
M. Neuenhahn et al.
LEUKEMIA (2017)
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
F. M. Marty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Burden of cytomegalovirus disease in solid organ transplant recipients: a national matched cohort study in an inpatient setting
Zalmai Hakimi et al.
TRANSPLANT INFECTIOUS DISEASE (2017)
CMV-Specific T Cell Monitoring Offers Superior Risk Stratification of CMV-Seronegative Kidney Transplant Recipients of a CMV-Seropositive Donor
Thomas Schachtner et al.
TRANSPLANTATION (2017)
Use of Cidofovir for Cytomegalovirus Disease Refractory to Ganciclovir in Solid Organ Recipients
Hugo Bonatti et al.
SURGICAL INFECTIONS (2017)
Diagnosis of cytomegalovirus pneumonia by quantitative polymerase chain reaction using bronchial washing fluid from patients with hematologic malignancies
Hwa Young Lee et al.
ONCOTARGET (2017)
Pharmacokinetics (PK) and Safety of Intravenous (IV) Brincidofovir (BCV) in Healthy Adult Subjects
Mary Beth Wire et al.
Open Forum Infectious Diseases (2017)
Comparison of Standardized Cytomegalovirus (CMV) Viral Load Thresholds in Whole Blood and Plasma of Solid Organ and Hematopoietic Stem Cell Transplant Recipients with CMV Infection and Disease
M. Veronica Dioverti et al.
OPEN FORUM INFECTIOUS DISEASES (2017)
Cytomegalovirus (CMV) immune monitoring with ELISPOT and QuantiFERON-CMV assay in seropositive kidney transplant recipients
Hyeyoung Lee et al.
PLOS ONE (2017)
Long-term control of recurrent or refractory viral infections after allogeneic HSCT with third-party virus-specific T cells
Barbara Withers et al.
BLOOD ADVANCES (2017)
An Interventional Study Using Cell-Mediated Immunity to Personalize Therapy for Cytomegalovirus Infection After Transplantation
D. Kumar et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2017)
Risk Factors and Outcomes of Ganciclovir-Resistant Cytomegalovirus Infection in Solid Organ Transplant Recipients
Cynthia E. Fisher et al.
CLINICAL INFECTIOUS DISEASES (2017)
CMV viral load in bronchoalveolar lavage for diagnosis of pneumonia in allogeneic hematopoietic stem cell transplantation
L. Iglesias et al.
BONE MARROW TRANSPLANTATION (2017)
Tissue polymerase chain reaction for the diagnosis of cytomegalovirus disease after allogeneic hematopoietic cell transplantation
Armin Rashidi et al.
AMERICAN JOURNAL OF HEMATOLOGY (2017)
Characterization of Cytomegalovirus Breakthrough Events in a Phase 2 Prophylaxis Trial of Letermovir (AIC246, MK 8228)
Peter Lischka et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Polyfunctional T-Cell Signatures to Predict Protection from Cytomegalovirus after Lung Transplantation
Laurie D. Snyder et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
The Cell Biology of Cytomegalovirus: Implications for Transplantation
H. Kaminski et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2016)
A First-in-Human Study To Assess the Safety and Pharmacokinetics of Monoclonal Antibodies against Human Cytomegalovirus in Healthy Volunteers
Kiran Dole et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Brincidofovir (CMX-001) for refractory and resistant CMV and HSV infections in immunocompromised cancer patients: A single-center experience
Danielle El-Haddad et al.
ANTIVIRAL RESEARCH (2016)
Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis
Pierre Teira et al.
BLOOD (2016)
How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients
Firas El Chaer et al.
BLOOD (2016)
Are We There Yet? Impact of the First International Standard for Cytomegalovirus DNA on the Harmonization of Results Reported on Plasma Samples
Jutta K. Preiksaitis et al.
CLINICAL INFECTIOUS DISEASES (2016)
Cytomegalovirus Vaccines: Current Status and Future Prospects
K. M. Anderholm et al.
DRUGS (2016)
Efficacy and Safety of Low-Dose Versus Standard-Dose Valganciclovir for Prevention of Cytomegalovirus Disease in Intermediate-Risk Kidney Transplant Recipients
Medhat A. Halim et al.
EXPERIMENTAL AND CLINICAL TRANSPLANTATION (2016)
Comparative Performance of Reagents and Platforms for Quantitation of Cytomegalovirus DNA by Digital PCR
R. T. Hayden et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2016)
The use of brincidofovir for the treatment of mixed dsDNA viral infection
Jose F. Camargo et al.
JOURNAL OF CLINICAL VIROLOGY (2016)
Quantiferon CMV assay in allogenic stem cell transplant patients
Patrizia Bono et al.
JOURNAL OF CLINICAL VIROLOGY (2016)
Successful low-dose leflunomide treatment for ganciclovir-resistant cytomegalovirus infection with high-level antigenemia in a kidney transplant: A case report and literature review
Shinya Morita et al.
JOURNAL OF CLINICAL VIROLOGY (2016)
Contribution of next generation sequencing to early detection of cytomegalovirus UL97 emerging mutants and viral subpopulations analysis in kidney transplant recipients
Isabelle Garrigue et al.
JOURNAL OF CLINICAL VIROLOGY (2016)
Utility of the Enzyme-Linked Immunospot Interferon-γ-Release Assay to Predict the Risk of Cytomegalovirus Infection in Hematopoietic Cell Transplant Recipients
Lior Nesher et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Case report: Brincidofovir-induced reversible severe acute kidney injury in 2 solid-organ transplant for treatment of cytomegalovirus infection
Emmanuel Faure et al.
MEDICINE (2016)
Sensitivity of blood and tissue diagnostics for gastrointestinal cytomegalovirus disease in solid organ transplant recipients
C. E. Fisher et al.
TRANSPLANT INFECTIOUS DISEASE (2016)
The Immunology of Posttransplant CMV Infection: Potential Effect of CMV Immunoglobulins on Distinct Components of the Immune Response to CMV
Javier Carbone
TRANSPLANTATION (2016)
Outcomes in Transplant Recipients Treated With Foscarnet for Ganciclovir-Resistant or Refractory Cytomegalovirus Infection
Robin K. Avery et al.
TRANSPLANTATION (2016)
Cytomegalovirus Infection and Rates of Antiviral Resistance Following Intestinal and Multivisceral Transplantation
T. Ambrose et al.
TRANSPLANTATION PROCEEDINGS (2016)
Detection of Low Frequency Multi-Drug Resistance and Novel Putative Maribavir Resistance in Immunocompromised Pediatric Patients with Cytomegalovirus
Charlotte J. Houldcroft et al.
FRONTIERS IN MICROBIOLOGY (2016)
Search continues for a CMV vaccine for transplant recipients
Michael Boeckh et al.
LANCET HAEMATOLOGY (2016)
Viraemia, immunogenicity, and survival outcomes of cytomegalovirus chimeric epitope vaccine supplemented with PF03512676 (CMVPepVax) in allogeneic haemopoietic stem-cell transplantation: randomised phase 1b trial
Ryotaro Nakamura et al.
LANCET HAEMATOLOGY (2016)
Cytomegalovirus viral load and mortality after haemopoietic stem cell transplantation in the era of pre-emptive therapy: a retrospective cohort study
Margaret L. Green et al.
LANCET HAEMATOLOGY (2016)
Efficacy and Safety of a Preemptive Antiviral Therapy Strategy Based on Combined Virological and Immunological Monitoring for Active Cytomegalovirus Infection in Allogeneic Stem Cell Transplant Recipients
David Navarro et al.
OPEN FORUM INFECTIOUS DISEASES (2016)
Adoptive T Cell Immunotherapy for Treatment of Ganciclovir-Resistant Cytomegalovirus Disease in a Renal Transplant Recipient
N. Macesic et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2015)
Valganciclovir for the Prevention of Complications of Late Cytomegalovirus Infection After Allogeneic Hematopoietic Cell Transplantation A Randomized Trial
Michael Boeckh et al.
ANNALS OF INTERNAL MEDICINE (2015)
Rapid In Vitro Evolution of Human Cytomegalovirus UL56 Mutations That Confer Letermovir Resistance
Sunwen Chou
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Recent Advances in Cytomegalovirus: An Update on Pharmacologic and Cellular Therapies
Michael Boeckh et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Adaptive Natural Killer Cell and Killer Cell Immunoglobulin-Like Receptor-Expressing T Cell Responses are Induced by Cytomegalovirus and Are Associated with Protection against Cytomegalovirus Reactivation after Allogeneic Donor Hematopoietic Cell Transplantation
Zachary B. Davis et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Reduced Mortality of Cytomegalovirus Pneumonia After Hematopoietic Cell Transplantation Due to Antiviral Therapy and Changes in Transplantation Practices
Veronique Erard et al.
CLINICAL INFECTIOUS DISEASES (2015)
Commutability of the First World Health Organization International Standard for Human Cytomegalovirus
R. T. Hayden et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2015)
Human Cytomegalovirus gH/gL/gO Promotes the Fusion Step of Entry into All Cell Types, whereas gH/gL/UL128-131 Broadens Virus Tropism through a Distinct Mechanism
Momei Zhou et al.
JOURNAL OF VIROLOGY (2015)
The history of vaccination against cytomegalovirus
Stanley Plotkin
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2015)
Letermovir and inhibitors of the terminase complex: a promising new class of investigational antiviral drugs against human cytomegalovirus
Dante P. Melendez et al.
INFECTION AND DRUG RESISTANCE (2015)
Diagnostic Usefulness of Cytomegalovirus (CMV)-Specific T Cell Immunity in Predicting CMV Infection after Kidney Transplantation: A Pilot Proof-of-Concept Study
Sung-Han Kim et al.
INFECTION AND CHEMOTHERAPY (2015)
Adoptive T-cell immunotherapy for ganciclovir-resistant CMV disease after lung transplantation
Chien-Li Holmes-Liew et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2015)
Use of Leflunomide in Renal Transplant Recipients with Ganciclovir-Resistant/Refractory Cytomegalovirus Infection: A Case Series from the University of Chicago
W. James Chon et al.
CASE REPORTS IN NEPHROLOGY AND DIALYSIS (2015)
Geno- and Phenotypic Characterization of Human Cytomegalovirus Mutants Selected In Vitro after Letermovir (AIC246) Exposure
Thomas Goldner et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Improved Detection of Emerging Drug-Resistant Mutant Cytomegalovirus Subpopulations by Deep Sequencing
Sunwen Chou et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Success and failure of artesunate treatment in five transplant recipients with disease caused by drug-resistant cytomegalovirus
R. Germi et al.
ANTIVIRAL RESEARCH (2014)
Preformed Frequencies of Cytomegalovirus (CMV)-Specific Memory T and B Cells Identify Protected CMV-Sensitized Individuals Among Seronegative Kidney Transplant Recipients
Marc Lucia et al.
CLINICAL INFECTIOUS DISEASES (2014)
Donor Cytomegalovirus Status Influences the Outcome of Allogeneic Stem Cell Transplant: A Study by the European Group for Blood and Marrow Transplantation
Per Ljungman et al.
CLINICAL INFECTIOUS DISEASES (2014)
The role of cytomegalovirus serostatus on outcome of hematopoietic stem cell transplantation
Per Ljungman
CURRENT OPINION IN HEMATOLOGY (2014)
A multiplexed droplet digital PCR assay performs better than qPCR on inhibition prone samples
Ruth Hall Sedlak et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2014)
Favorable impact of natural killer cell reconstitution on chronic graft-versus-host disease and cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation
Vissal David Kheav et al.
HAEMATOLOGICA (2014)
Clinical Utility of Droplet Digital PCR for Human Cytomegalovirus
Ruth Hall Sedlak et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2014)
Evaluation of CMV-specific cellular immune response by EliSPOT assay in kidney transplant patients
Cristina Costa et al.
JOURNAL OF CLINICAL VIROLOGY (2014)
Detection of cytomegalovirus (CMV) by real-time PCR in fecal samples for the non-invasive diagnosis of CMV intestinal disease
Tina Ganzenmueller et al.
JOURNAL OF CLINICAL VIROLOGY (2014)
Letermovir for Cytomegalovirus Prophylaxis in Hematopoietic-Cell Transplantation
Roy F. Chemaly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Activity of Broad-Spectrum T Cells as Treatment for AdV, EBV, CMV, BKV, and HHV6 Infections after HSCT
Anastasia Papadopoulou et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Preemptive treatment of Cytomegalovirus infection in kidney transplant recipients with letermovir: results of a Phase 2a study
Susanne Stoelben et al.
TRANSPLANT INTERNATIONAL (2014)
A Comparison of CMV Detection in Gastrointestinal Mucosal Biopsies Using Immunohistochemistry and PCR Performed on Formalin-fixed, Paraffin-embedded Tissue
Anne M. Mills et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)
CMV: Prevention, Diagnosis and Therapy
C. N. Kotton
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Detection of human cytomegalovirus in transbronchial biopsies from lung transplant recipients
Cristina Costa et al.
ARCHIVES OF VIROLOGY (2013)
CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of EBMT
Martin Schmidt-Hieber et al.
BLOOD (2013)
Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation
Ann M. Leen et al.
BLOOD (2013)
Fast selection of maribavir resistant cytomegalovirus in a bone marrow transplant recipient
Axel Schubert et al.
BMC INFECTIOUS DISEASES (2013)
Assessment of Cytomegalovirus-Specific Cell-Mediated Immunity for the Prediction of Cytomegalovirus Disease in High-Risk Solid-Organ Transplant Recipients: A Multicenter Cohort Study
Oriol Manuel et al.
CLINICAL INFECTIOUS DISEASES (2013)
Detection of Cytomegalovirus DNA in Plasma as an Adjunct Diagnostic for Gastrointestinal Tract Disease in Kidney and Liver Transplant Recipients
Christine M. Durand et al.
CLINICAL INFECTIOUS DISEASES (2013)
Detection of Cytomegalovirus Drug Resistance Mutations by Next-Generation Sequencing
Malaya K. Sahoo et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
Quantitation of Cytomegalovirus DNA Load in Dried Blood Spots Correlates Well with Plasma Viral Load
Ajit P. Limaye et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
Dynamics of cytomegalovirus populations harbouring mutations in genes 1JL54 and 1JL97 in a haematopoietic stern cell transplant recipient
Nathalie Schnepf et al.
JOURNAL OF CLINICAL VIROLOGY (2013)
Decreased incidence of cytomegalovirus infection with sirolimus in a post hoc randomized, multicenter study in Lung transplantation
Bijan Ghassemieh et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2013)
Safety and Immunogenicity of Modified Vaccinia Ankara in Hematopoietic Stem Cell Transplant Recipients: A Randomized, Controlled Trial
Stephen R. Walsh et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
CMX001 to Prevent Cytomegalovirus Disease in Hematopoietic-Cell Transplantation
Francisco M. Marty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Everolimus is associated with a reduced incidence of cytomegalovirus infection following de novo cardiac transplantation
J. Kobashigawa et al.
TRANSPLANT INFECTIOUS DISEASE (2013)
Leflunomide as part of the treatment for multidrug-resistant cytomegalovirus disease after lung transplantation: case report and review of the literature
N. J. Verkaik et al.
TRANSPLANT INFECTIOUS DISEASE (2013)
Updated International Consensus Guidelines on the Management of Cytomegalovirus in Solid-Organ Transplantation
Camille N. Kotton et al.
TRANSPLANTATION (2013)
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients
Elisabeth M. Hodson et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2013)
Efficacy and Safety of Maribavir Dosed at 100 mg Orally Twice Daily for the Prevention of Cytomegalovirus Disease in Liver Transplant Recipients: A Randomized, Double-Blind, Multicenter Controlled Trial
D. J. Winston et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Efficacy of a Viral Load-Based, Risk-Adapted, Preemptive Treatment Strategy for Prevention of Cytomegalovirus Disease after Hematopoietic Cell Transplantation
Margaret L. Green et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial
Mohamed A. Kharfan-Dabaja et al.
LANCET INFECTIOUS DISEASES (2012)
Leflunomide for cytomegalovirus: bench to bedside
B. Chacko et al.
TRANSPLANT INFECTIOUS DISEASE (2012)
Cytomegalovirus disease and infection in lung transplant recipients in the setting of planned indefinite valganciclovir prophylaxis
A. P. Wiita et al.
TRANSPLANT INFECTIOUS DISEASE (2012)
Valganciclovir Prophylaxis Versus Preemptive Therapy in Cytomegalovirus-Positive Renal Allograft Recipients: 1-Year Results of a Randomized Clinical Trial
Oliver Witzke et al.
TRANSPLANTATION (2012)
Directly Selected Cytomegalovirus-Reactive Donor T Cells Confer Rapid and Safe Systemic Reconstitution of Virus-Specific Immunity Following Stem Cell Transplantation
Karl S. Peggs et al.
CLINICAL INFECTIOUS DISEASES (2011)
Long-term efficacy and safety of 12 months of valganciclovir prophylaxis compared with 3 months after lung transplantation: A single-center, long-term follow-up analysis from a randomized, controlled cytomegalovirus prevention trial
C. Ashley Finlen Copeland et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2011)
Primary Cytomegalovirus Phosphoprotein 65-Specific CD8+ T-Cell Responses and T-bet Levels Predict Immune Control During Early Chronic Infection in Lung Transplant Recipients
Matthew R. Pipeling et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial
Paul D. Griffiths et al.
LANCET (2011)
Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial
Francisco M. Marty et al.
LANCET INFECTIOUS DISEASES (2011)
Pyrosequencing allows the detection of emergent ganciclovir resistance mutations after HCMV infection
Susanne E. Kampmann et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2011)
Adoptive transfer and selective reconstitution of streptamer-selected cytomegalovirus-specific CD8+ T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantation
Anita Schmitt et al.
TRANSFUSION (2011)
Clinical Utility of Molecular Surveillance for Cytomegalovirus After Antiviral Prophylaxis in High-Risk Solid Organ Transplant Recipients
Luiz F. Lisboa et al.
TRANSPLANTATION (2011)
Impact of a Preemptive Strategy After 3 Months of Valganciclovir Cytomegalovirus Prophylaxis in Kidney Transplant Recipients
Noemie Boillat Blanco et al.
TRANSPLANTATION (2011)
Diagnostic value of antigenemia assay for cytomegalovirus gastrointestinal disease in immunocompromised patients
Naoyoshi Nagata et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Maribavir and human cytomegalovirus-what happened in the clinical trials and why might the drug have failed?
Francisco M. Marty et al.
CURRENT OPINION IN VIROLOGY (2011)
The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High-Risk Kidney Transplant Recipients
A. Humar et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Improved Detection of Mutated Human Cytomegalovirus UL97 by Pyrosequencing
Birgit Schindele et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation
Tobias Feuchtinger et al.
BLOOD (2010)
Cytomegalovirus Resistance Testing: Pitfalls and Problems for the Clinician
W. Lawrence Drew
CLINICAL INFECTIOUS DISEASES (2010)
Antiviral Drug Resistance of Human Cytomegalovirus
Nell S. Lurain et al.
CLINICAL MICROBIOLOGY REVIEWS (2010)
Choice of induction regimens on the risk of cytomegalovirus infection in donor-positive and recipient-negative kidney transplant recipients
F. L. Luan et al.
TRANSPLANT INFECTIOUS DISEASE (2010)
Cytomegalovirus risk factors in renal transplantation with modern immunosuppression
S. Bataille et al.
TRANSPLANT INFECTIOUS DISEASE (2010)
Lower incidence of cytomegalovirus infection with everolimus versus mycophenolate mofetil in de novo cardiac transplant recipients: a randomized, multicenter study
M. Vigano et al.
TRANSPLANT INFECTIOUS DISEASE (2010)
Preemptive Versus Sequential Prophylactic-Preemptive Treatment Regimens for Cytomegalovirus in Renal Transplantation: Comparison of Treatment Failure and Antiviral Resistance
Martha T. van der Beek et al.
TRANSPLANTATION (2010)
Utility of Leflunomide in the Treatment of Complex Cytomegalovirus Syndromes
Robin K. Avery et al.
TRANSPLANTATION (2010)
Early and Delayed Onset Cytomegalovirus Infection of Liver Transplant Recipients in Endemic Areas
J. M. Kim et al.
TRANSPLANTATION PROCEEDINGS (2010)
Adoptive T-Cell Therapy of a Lung Transplanted Patient with Severe CMV Disease and Resistance to Antiviral Therapy
G. Brestrich et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
The 'Indirect' Effects of Cytomegalovirus Infection
R. B. Freeman
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Interferon Gamma 13-CA-Repeat Homozygous Genotype and a Low Proportion of CD4+ Lymphocytes Are Independent Risk Factors for Cytomegalovirus Reactivation with a High Number of Copies in Hematopoietic Stem Cell Transplantation Recipients
Emilia Jaskula et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
How I treat cytomegalovirus in hematopoietic cell transplant recipients
Michael Boeckh et al.
BLOOD (2009)
Prophylactic Therapy With Valgancyclovir in High-Risk (Cytomegalovirus D+/R-) Liver Transplant Recipients: A Single-Center Experience
M. Montejo et al.
TRANSPLANTATION PROCEEDINGS (2009)
Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study
Drew J. Winston et al.
BLOOD (2008)
Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation
Supha K. Arthurs et al.
CLINICAL INFECTIOUS DISEASES (2008)
Artesunate as a potent antiviral agent in a patient with late drug-resistant cytomegalovirus infection after hematopoietic stem cell transplantation
Michael Y. Shapira et al.
CLINICAL INFECTIOUS DISEASES (2008)
Predictors for persistent cytomegalovirus reactivation after T-cell-depleted allogeneic hematopoietic stem cell transplantation
N. G. Almyroudis et al.
TRANSPLANT INFECTIOUS DISEASE (2007)
Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignancies
E. Oezdemir et al.
BONE MARROW TRANSPLANTATION (2007)
The natural course of cytomegalovirus infection and disease in renal transplant recipients
Anders Hartmann et al.
TRANSPLANTATION (2006)
Impact of cytomegalovirus in organ transplant recipients in the era of antiviral prophylaxis
Ajit P. Limaye et al.
TRANSPLANTATION (2006)
The anti-malaria drug artesunate inhibits replication of cytomegalovirus in vitro and in vivo
SJF Kaptein et al.
ANTIVIRAL RESEARCH (2006)
Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism
D Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects
AW Sylwester et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Human cytomegalovirus UL131 open reading frame is required for epithelial cell tropism
D Wang et al.
JOURNAL OF VIROLOGY (2005)
Genetic content of wild-type human cytomegalovirus
A Dolan et al.
JOURNAL OF GENERAL VIROLOGY (2004)
Clinical significance of cytomegalovirus (CMV) antigenemia in the prediction and diagnosis of CMV gastrointestinal disease after allogeneic hematopoietic stem cell transplantation
T Mori et al.
BONE MARROW TRANSPLANTATION (2004)
Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes
G Hahn et al.
JOURNAL OF VIROLOGY (2004)
Immune evasion proteins of human cytomegalovirus do not prevent a diverse CD8+ cytotoxic T-cell response in natural infection
TJ Manley et al.
BLOOD (2004)
Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival
S Sagedal et al.
KIDNEY INTERNATIONAL (2004)
Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines
KS Peggs et al.
LANCET (2003)
Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation
M Hakki et al.
BLOOD (2003)
Dynamics of cytomegalovirus replication during preemptive therapy with oral ganciclovir
RR Razonable et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Ex vivo profiling of CD8+-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers
R Elkington et al.
JOURNAL OF VIROLOGY (2003)
Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity
M Boeckh et al.
BLOOD (2003)
The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients
S Sagedal et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2002)
Cytomegalovirus (CMV) virus load kinetics to predict recurrent disease in solid-organ transplant patients with CMV disease
A Humar et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of action
KK Biron et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Cytomegalovirus DNA concentration in plasma predicts development of cytomegalovirus disease in kidney transplant recipients
H Rollag et al.
CLINICAL MICROBIOLOGY AND INFECTION (2002)
Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy
H Einsele et al.
BLOOD (2002)
Distinguishing cytomegalovirus (CMV) infection and disease with CMV nucleic acid assays
AM Caliendo et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2002)
The clinical use of various blood compartments for cytomegalovirus (CMV) DNA quantitation in transplant recipients with CMV disease
RR Razonable et al.
TRANSPLANTATION (2002)
Experiences with leflunomide in solid organ transplantation
JW Williams et al.
TRANSPLANTATION (2002)
High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: Evidence for indirect effects of primary CMV infection
WG Nichols et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
High incidence of ganciclovir-resistant cytomegalovirus infection among lung transplant recipients receiving preemptive therapy
AP Limaye et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
A canarypox vector-expressing cytomegalovirus (CMV) phosphoprotein 65 induces long-lasting cytotoxic T cell responses in human CMV-seronegative subjects
K Berencsi et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients
P Ljungman et al.
BLOOD (2001)
Randomized, placebo-controlled, double-blind study of a cytomegalovirus-specific monoclonal antibody (MSL-109) for prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation
M Boeckh et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2001)
Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants
AP Limaye et al.
LANCET (2000)
Prediction of cytomegalovirus load and resistance patterns after antiviral chemotherapy
VC Emery et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation
VC Emery et al.
LANCET (2000)
Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection
H Einsele et al.
BONE MARROW TRANSPLANTATION (2000)
Comparison of PCR, antigenemia assay, and rapid blood culture for detection and prevention of cytomegalovirus disease after lung transplantation
A Weinberg et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2000)
分享论文
